The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EMN 2018 | Clonal evolution in MM: MGUS and SMM
Nicola Giuliani
• 19 Apr 2018
Nicola Giuliani, MD, PhD, from the University of Parma, Parma, Italy, talks about the clinical approach required when identifying and treating patients with smoldering myeloma. Dr Giuliani was speaking at the 1st European Myeloma Network (EMN) Meeting, held in Turin, Italy.
